Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹ÀÎ ÅΰüÀýÀå¾Ö ȯÀÚÀÇ À¯º´·ü°ú Áø·á ¾çÅÂ

Prevalence and Treatment Pattern of Korean Patients with Temporomandibular Disorders

´ëÇѱ¸°­³»°úÇÐȸÁö 2009³â 34±Ç 1È£ p.63 ~ 79
¾çÈñ¿µ, ±è¹ÌÀº,
¼Ò¼Ó »ó¼¼Á¤º¸
¾çÈñ¿µ ( Yang Hee-Young ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
±è¹ÌÀº ( Kim Mee-Eun ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç

Abstract

º» ¿¬±¸´Â °Ç°­º¸Çè½É»çÆò°¡¿ø(Health Insurance Review and Assessment Service, ÀÌÇÏ ½ÉÆò¿ø)¿¡¼­ Àü»êÈ­µÇ¾î °ü¸®µÇ´Â º¸Çè´ë»ó ȯÀÚµéÀÇ Áø·á±â·ÏÀ» ÀÌ¿ëÇÏ¿© ÅΰüÀýÀå¾Ö(temporomandibular disorders, TMD)·Î ÀÎÇØ º´¿øÀ» ã°í Àִ ȯÀÚÀÇ À¯º´·ü°ú Áø·á¾çŸ¦ ÆľÇÇÏ°íÀÚ ÇÏ¿´´Ù. ¿¬±¸¸¦ À§ÇÏ¿© ½ÉÆò¿ø Àü»ê½Ã½ºÅÛ¿¡ µî·ÏµÈ ±¹³» º¸Çè´ë»ó ȯÀÚ Áß 2003³â, 2004³â, 2005³âÀÇ 3³â¿¡ °ÉÄ£ ȯÀÚ ÀڷḦ »ç¿ëÇÏ¿© ÅΰüÀýÀå¾Ö (K07.6)¸¦ ÁÖ»óº´À¸·Î ÇÏ¿© Áø´Ü°ú Ä¡·á¸¦ ¹ÞÀº ȯÀÚ¿¡ ´ëÇÏ¿© ¼ºº° ¹× ¿¬·Éº° Áø·áÀοø, Áö¿ªº° Áø·áÀοø, ¿ä¾ç±â°üÁ¾º° Áø·áÀοø, Ä¡·á±â°£ ¹× Áø·á°Ç¼ö, Áø·á°ú¸ñº° Áø·á°Ç¼ö¿Í Æò±ÕÄ¡·á±â°£, Áø·á°ú¸ñº° 1ÀÎ´ç ¼Ò¿äºñ¿ë, ¿ø¿Üó¹æ Ä¡·á¾àÁ¦ ¾àÈ¿ºÐ·ùÄÚµå(È¿´É±º)º° ¿¬°£ Åõ¾àÀϼö, ¿Ü°úÀû ¼ö¼ú ½Ç½Ã Ƚ¼ö µîÀ» ºÐ¼®Á¶»çÇÑ ¿¬±¸°á°ú´Â ´ÙÀ½°ú °°´Ù. TMD·Î ÀÎÇØ º´¿øÀ» ã´Â Æò±Õ ȯÀÚ¼ö´Â ÀüüÀα¸ÀÇ 0.15%À̾úÀ¸¸ç, 3³â°£ ¸Å³â Áõ°¡ÇÏ´Â Ãß¼¼¸¦ º¸¿´´Ù. ±× Áß 99.8%°¡ ¿©ÀÚ¿´°í, 20´ëÀÇ À¯º´·üÀÌ °¡Àå ³ô°í ¿¬·ÉÀÌ Áõ°¡Çϸ鼭 °¨¼ÒÇÏ´Â ¾ç»óÀ» º¸¿´´Ù. 3³â°£ÀÇ º¯È­ÃßÀ̸¦ º¼ ¶§ 20´ëÀÇ À¯º´·üÀº °¨¼ÒÇÏ°í 40´ë ÀÌÈÄ Áõ°¡ÇÏ´Â ¾ç»óÀ» º¸¿´´Ù´Â Á¡ÀÌ Æ¯Â¡ÀûÀ̾ú´Ù. 16°³ ½Ãµµº° ºÐÆ÷¿¡¼­´Â Àα¸°¡ ¸¹Àº ¼­¿ï, °æ±â Áö¿ªÀÇ È¯ÀÚ¼ö°¡ ¸¹¾Ò°í, ¸Å³â Àüü ȯÀÚ¼ö°¡ Áõ°¡Çϸ鼭 °¢ Áö¿ªº°·Î À¯»çÇÑ ºñÀ²·Î Áõ°¡ÇÏ¿´´Ù. ±×·¯³ª ºÎ»ê°ú ´ë±¸¿¡¼­´Â °¨¼Ò¼¼°¡ ¶Ñ·ÇÇÏ¿´°í ¿ï»ê, °æ±â, Àü³²ÀÇ Áõ°¡¼¼°¡ °üÂûµÇ¾ú´Ù. ÀÇ·á±â°üº°·Î ³»¿øÇÑ È¯ÀÚ ¼ö´Â Ä¡°ú¸¦ Æ÷ÇÔÇÑ ÀÏÂ÷ÀÇ·á±â°ü¿¡ ³»¿øÇÏ¿© Áø·áÇÑ °æ¿ì°¡ Æò±Õ 56.8%·Î ÀüüÀÇ °ú¹Ý¼ö¸¦ Â÷ÁöÇÏ¿´°í TMD¿Í °ü·ÃÇÑ ÀÔ¿ø°Ç¼ö´Â Ä¡°ú ÀÔ¿ø(86.6%)ÀÌ ÀÇ°úÀüü(13.4%) º¸´Ù ÈξÀ ¸¹¾Ò´Ù. ¿Ü·¡³»¿ø°Ç¼ö¿¡¼­´Â Ä¡°ú°¡ Àüü °Ç¼öÀÇ 38.4%·Î¼­ °¡Àå ¸¹¾ÒÀ¸¸ç, Á¤Çü¿Ü°ú(28%), À̺ñÀÎÈÄ°ú(13.6%)ÀÇ ¼ø¼­¿´´Ù. ¾à¹°Ä¡·á¿¡¼­´Â ÇØ¿­¼Ò¿°ÁøÅëÁ¦°¡ °¡Àå ºó¹øÇÏ°Ô Åõ¿©µÇ¾ú°í Á¤½Å½Å°æ¿ëÁ¦, °ñ°Ý±ÙÀÌ¿ÏÁ¦ÀÇ ¼ø¼­¿´´Ù. ½ÉÆò¿øÀÇ ÀÚ·á´Â TMD¶§¹®¿¡ º´¿øÀ» ã´Â ȯÀÚµéÀÇ ¿ªÇÐÀû Ư¼º°ú Áø·á¾çÅ¿¡ ´ëÇÑ Æ÷°ýÀûÀÌ°í ±¤¹üÀ§ÇÑ Á¤º¸¸¦ Á¦°øÇÏ°í ÀÖÁö¸¸, Áø·á½Ç¿¡¼­ Á¤È®ÇÑ Áø´Ü°ú Ç¥ÁØÈ­µÈ Ä¡·á°¡ ÀÌ·ç¾îÁö°í ÀÖ´ÂÁö¿¡ ´ëÇÑ Æò°¡°¡ ÇÔ²² ÀÌ·ç¾îÁú ¶§ ´õ¿í ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¤º¸°¡ µÉ °ÍÀ¸·Î »ý°¢µÈ´Ù.

While previous epidemiological studies on temporomandibular disorders (TMD) have been based on a given health center or population sample, no study has been performed on general population of Korea, especially concerning about treatment pattern such as clinician¡¯s specialty involved in TMD treatment, types and amount of prescription medication and cost. This study aimed to investigate magnitude of health visits and treatment patterns for Korean patients with TMD through the computerized database of Health Insurance Review and Assessment Service (HIRAS). Inclusion criteria were all patients registered on the HIRAS database over 3 years¡¯ period from 2003 to 2005 and the medical records of patients with TMD as a main diagnosis were extracted. Information collected was as follows; distribution related to gender, age and region and type of hospital the patients visited, treatment duration, clinicians¡¯ specialty involved in treatment, cost, types of rescription medication and surgical treatment. The results of this study indicated that 0.15% of the population yearly sought TMD treatment, presenting with increase of incidence over the three years. Most of TMD patients were women (99.8%) and the biggest age group was second and third decades and decreased with age. Seoul and Kyeonggi province presented with higher incidence of TMD compared to the other regions of Korea, which seems to be related with magnitude of population. 56% of TMD patients visited primary care sector and the numbers of treatment visits was the highest in dental clinic (38.4%), followed by orthopedics (28%) and ENT (13.6%) clinics in order. Duration of prescription medication was the longest for anti-inflammatory analgesics, followed by antipsychotic drugs and muscle relaxants. Inpatient care related to TMD was primarily performed in dental hospital compared to medical hospital. Medical database of HIRAS provided comprehensive and vast information on epidemiologic characteristics and treatment patterns for patients seeking TMD treatment, which can be more reliable data to expect medical demand for TMD in condition that accurate diagnosis and standardized treatment is delivered in clinical settings.

Å°¿öµå

ÅΰüÀýÀå¾Ö(ÃøµÎÇϾǰüÀýÀå¾Ö);¿ªÇÐ;°Ç°­º¸Çè½É»çÆò°¡¿ø(½ÉÆò¿ø);Çѱ¹
Temporomandibular disorders(TMD);Epidemiology;Health Insurance Review and Assessment Service(HIRAS);Korea

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI